A detailed history of Harbour Trust & Investment Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Harbour Trust & Investment Management CO holds 5,446 shares of LLY stock, worth $4.46 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
5,446
Previous 5,503 1.04%
Holding current value
$4.46 Million
Previous $4.98 Billion 3.16%
% of portfolio
0.55%
Previous 0.59%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $44,011 - $54,721
-57 Reduced 1.04%
5,446 $4.82 Billion
Q2 2024

Jul 23, 2024

SELL
$724.87 - $909.04 $50,016 - $62,723
-69 Reduced 1.24%
5,503 $4.98 Billion
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $207,862 - $278,090
351 Added 6.72%
5,572 $4.33 Billion
Q4 2023

Jan 26, 2024

BUY
$525.19 - $619.13 $2.74 Million - $3.23 Million
5,221 New
5,221 $3.04 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Harbour Trust & Investment Management CO Portfolio

Follow Harbour Trust & Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Trust & Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Trust & Investment Management CO with notifications on news.